Investors Lighted $228M Fire Under Massachusetts Startups in September
Summary
The tallies come from data provided to Xconomy by ChubbyBrain, a New York-based information services company developing tools for investors, startups, and aspiring entrepreneurs.The largest was a $30 million Series C round for Seaside Therapeutics, a stealthy Cambridge biotech based on research at MIT that is out to create the first drugs designed to treat the neurological disorder underlying patients with Fragile X syndrome and autism.round for Ironwood Pharmaceuticals, also of Cambridge, which is developing a drug to treat irritable bowel syndrome.Verivue, a Westford-based provider of multimedia distribution switches for cable and telecom operators, brought in $20.1 million, good enough for third place.The Taunton firm, which Ryan profiled, brought in $18 million in the month’s biggest A round, and the fifth-biggest deal overall.